AI-generated summary
The authors pooled eight studies of repeated low-level red-light therapy combined with orthokeratology or defocus incorporated multiple segment spectacles in children with myopia. They report that the combination was associated with less axial elongation, slower refraction progression and greater choroidal thickening than optical treatment alone, with no significant short-term difference in ocular surface adverse events. The authors note heterogeneity, regional concentration of data, and that the findings are early signals rather than definitive evidence.
- Studies included
- 8
- Who or what was studied
- Pediatric patients with myopia
- Limits stated in the abstract
- The abstract notes heterogeneity and regional concentration of data, and that findings are early biological signals rather than definitive evidence of long-term superiority.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Repeated low-level red-light (RLRL) therapy, a photobiomodulation approach for myopia control, has shown potential in modulating choroidal and axial structures. Recent studies have combined RLRL with optical interventions such as orthokeratology (OK) and defocus incorporated multiple segment (DIMS) spectacles. However, the efficacy and safety of these combinations remain unclear. This study synthesized current evidence on RLRL combined with optical interventions for pediatric myopia control.
Methods
A systematic search of PubMed, EMBASE, Cochrane Library, Web of Science, CNKI and Wanfang Data was conducted up to July 14, 2025. Randomized and cohort studies comparing RLRL combined with OK or DIMS versus monotherapy were included. Primary outcomes were axial length (AL), spherical equivalent refraction (SER), and subfoveal choroidal thickness (SFChT). Fixed- or random-effects models were used based on heterogeneity. Risk of bias was assessed with ROB2 and ROBINS-I.
Results
Eight studies were included. Compared with optical monotherapy, combination therapy was associated with reduced axial elongation, slower SER progression, and greater increases in SFChT. Structural changes were observed as early as 1 month and persisted through 12 months. No significant differences were detected in short-term ocular surface adverse events. However, heterogeneity and regional concentration of data were noted.
Conclusions
Adjunctive RLRL therapy may enhance optical myopia control effects, particularly in reducing axial elongation and increasing choroidal thickness, possibly through choroidal modulation. These findings should be viewed as early biological signals, not definitive evidence of long-term superiority. Larger multicenter randomized trials with extended follow-up are needed to confirm durability, safety, and dose-response characteristics.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Myopia, Repeated low-level red light, Meta-analysis, Heterogeneity, Photobiomodulation, Risk of bias, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.